added since. Most of the emphasis in recent years has been on the prognostic and therapeutic implications# of the in-situ variety and on its mammographic recognition. The infiltrative form of lobular carcinoma also has a distinctive microscopic appearance (McDivitt et al, 1968) . One of the many curious aspects of lobular carcinoma is the distinction between it and so-called cancerization of lobules (Fechner, 1971) , a distinction which is maintained in the infiltrative phase of the respective tumours. Hamperl (1972) has suggested that it is of myoepithelial cell derivation.
Impressed by the generally accepted observation that it originates in lobules and yet forms no ductal structures as seen with 'scirrhous carcinoma'
(infiltrating duct carcinoma), it occurred to us that lobular carcinoma might represent a variant of a secretory type of tumour. To our surprise we found no mention of mucin study in the now extensive literature on lobular carcinoma of the breast.
Materials and Methods
Twenty cases of lobular carcinoma of the breast were selected for study. These were taken from the files of the Department of Histopathology at the Royal Postgraduate Medical School. The 20
Received for publication 12 March 1975. tumours were from 19 different patients since, though four of these patients had bilateral primary tumours, the second tumour was removed in three cases outside the period of study. Of the 20 cases, 10 had lobular carcinoma in-situ only, three had in-situ and infiltrating lobular carcinoma, and seven had infiltrating lobular carcinoma in the blocks studied. The material included both excision biopsy and mastectomy specimens. Patients in whom only lobular carcinoma in-situ was found were all operated on for what was clinically regarded as benign breast disease. The benign lesions found in these patients are not considered further here. For purposes of comparison with lobular carcinoma in-situ, six cases of cancerization of lobules as defined by Fechner (1971) were studied simultaneously by the same methods.
Tissues were fixed in 10% neutral buffered formalin and processed in routine fashion, and paraffin sections were cut at 5,u. In addition to haemalum eosin staining, a series of histochemical stains for mucosubstances as used by Gad (1969) was employed on all cases. This includes: periodic acid Schiff (PAS) with and without diastase pretreatment, alcian blue-periodic acid-Schiff sequence (AB/PAS) with and without nuclear counterstain with haemalum, alcian blue with neutral red nuclear counterstain (AB/NR), and high iron diamine alcian blue combination (HID/AB). Digestion experiments were carried out as follows:
for 24 hours at 370C. Removal 5) . But a 'target' appearance, with a central globule or dot separated by a space from an outer halo, is the characteristic pattern of this tumour, irrespective of the colour scheme in the AB/PAS stain (figs 3 and 4). The main qualitative difference from other carcinomas of the breast is the secretion by lobular carcinoma of a very small amount of sulphomucin, as demonstrated by the HID/AB combination. Mucoid carcinoma of the breast secretes sialomucin almost exclusively, and other breast carcinomas, including the common 'scirrhous', secrete both sialomucin and neutral mucosubstance (Gad, in preparation) . But it must be stressed that the amount of sulphomucin in lobular carcinomas is usually minimal. The major difference from other carcinomas of the breast is in the localization of the mucin-exclusively intracellular in the lobular variety, dominantly extracellular or in tubular structures in the mucoid and scirrhous varieties. While in scirrhous carcinoma the mucin is dominantly in tubular lumina, it must be pointed out that occasional tumour cells do contain intracellular mucin droplets indistinguishable from those of infiltrating lobular carcinoma. The proportion of cells containing such droplets is usually small, of the order of only 2 or 3% but it may reach 5%. In view of this, it is not possible to exclude some overlap in the pattern of mucin secretion of scirrhous and infiltrating lobular carcinoma.
The finding that lobular carcinoma is a mucinsecreting type of tumour is at variance with the view that it is exclusively a myoepithelial-cell cancer or dysplasia (Hamperl, 1972) . Clearly it is a tumour that differentiates towards epithelial cells and dominantly towards secretory cells. It is conceivable that lobular carcinoma shows differentiation towards myoepithelial cells as well as epithelial cells. This possibility must be considered in view of the work of authors who found 'large numbers of cytoplasmic fibrils similar in appearance to those seen in recognizable myoepithelial cells' at the ultrastructural level (Carter et al, 1969) . We are concerned at the frequency with which such fibrils are found in a whole variety of different tumours, for example, Wellings and Roberts (1963) found very similar appearances in infiltrating duct carcinoma. For present purposes, suffice it to say that identification of myofibrils in many tumours, Lobular carcinoma of the breast: a special variant ofmucin-secreting carcinoma including breast carcinomas, is fraught with difficulties, and that we have reservations about the type of evidence presented to date. Certainly the evidence that lobular carcinoma shows epithelial differentiation is incontrovertible.
The tumour cells secrete intracellular mucin globules and are 'dissociated' one from another, this being seen most clearly in the infiltrative phase. This is analogous with tumours in other organs (for example, stomach), in which tumours with dominantly intracellular mucin secretion show lack of cohesiveness, expressed as cell 'dissociation', associated with markedly infiltrative activity.
Staining for mucin with the AB/PAS combination is useful as a method of scanning breast tissue at low magnification both for the detection of lobular carcinoma in-situ as well as for mapping out the extent of lobular involvement and ductal Pagetoid spread. Lobular carcinoma in-situ is easily missed and there is reason to believe that it is not diagnosed as frequently as it should be. Mucin stains are of great value to those who are not very conversant with this disease: to the expert, admittedly, this method is only slightly better than scanning haemalum-eosin sections.
The constancy of the pattern of mucin secretion makes the distinction from other types of breast carcinoma easier and more objective. This helps in a number of practical ways. First, it adds a new criterion to the distinction between lobular carcinoma in-situ (LISC) and lobular cancerization, since in the latter most of the mucin is luminal. Secondly, Newman (1966) distinguished 'pure' and mixed forms of lobular carcinoma as he recognized that the distinction between lobular and ductal carcinoma was not always as clear-cut as in the classical forms of the diseases. In this situation an objective criterion, like that described here, should help in the differentiation. Thirdly, this method can help reduce some of the confusion that has crept into the literature. Some authors have not attempted to distinguish between ductal carcinoma and lobular carcinoma on the grounds that both are composed sometimes of what is called a 'small cell' (Toker, 1974) . Figures 10 and 11 of this author unfortunately do not represent the lesion described over the last three decades by the Memorial Hospital group of workers and many others. This lumping together of different entities, on the sole and dubious criterion of cell size, will confuse the essential quality of LISC, as ably summarized by Warner (1969) 
